No payment accepted from any clinic or pharmacy listed. No referral fees, no coupon codes, no partnerships.How we make money
← GLP Success
Comparison

Mochi Health vs SkinnyRx

Independent, side-by-side. Same methodology, same sourcing standard, no payment accepted from either. Prices are observed market pricing (snapshot 2026-07-20); receipts are computed from sourced records.

Mochi HealthSkinnyRx
VerdictProfile in progressProfile in progress
Tirzepatide pricefrom $278/mo (monthly plan)from $299/mo (12-mo prepay)
Semaglutide pricefrom $165/mo (3-mo prepay)from $199/mo (12-mo prepay)
Pharmacy receiptFills through DCA Pharmacy, Empower +2 per market data — Empower is an FDA-registered 503B outsourcing facility (federal cGMP oversight). Pick your state to check the rest.Fills through Foothills, Pharmacy Innovations +2 per market data (not the clinic's own disclosure). Pick your state to check licenses.
Care receiptOutsourced contract clinicians — the brand doesn't employ your clinician — with check-ins and coaching on record.Outsourced contract clinicians — the brand doesn't employ your clinician — with check-ins and coaching on record.
Review integrityClean review record — 5% unprompted on 4,934 reviews, within our 40% threshold.Review-integrity flag — 69% of its Trustpilot reviews are unprompted "organic" posts, past our 40% gaming threshold.
Company addressLists a real-looking operating address on its own site.Its listed address is a registered-agent or mailbox service — no operating location stands behind the brand's listed address.
PharmacyIn reviewIn review
Clinical supportIn reviewIn review
Patient supportIn reviewIn review
ValueIn reviewIn review
Ships to50 statesIn review
Pharmacy modelMarketplace model: Mochi routes prescriptions to a network of compounding pharmacies and says patients pick a partner pharmacy in the patient portal. Mochi does not publish a full list of its partner pharmacies. One reported affiliated pharmacy, Aequita Pharmacy of Kirkland, WA, was subject to a Washington State Limited Stop Service in March 2025 and reportedly closed in April 2025.SkinnyRx does not name a compounding or dispensing pharmacy anywhere on its own website or in its Terms and Conditions. Its FAQ states only, generically, that "503A pharmacies are licensed by state boards of pharmacy and are FDA-compliant." Notably, the FDA's February 2026 warning letter to SkinnyRx's operating company found that the compounded semaglutide/tirzepatide product labels pictured on skinnyrx.com display the name "SkinnyRx" itself, which the FDA determined falsely suggests SkinnyRx is the compounder of the drugs when in fact it is not — the actual compounder is left undisclosed to consumers. A federal class-action complaint filed against unrelated defendants (Foothills Professional Pharmacy, Ltd.; Avocado Health Technology, Inc.; Sajad Zalzala, M.D.; TeleRx Providers, P.C.) separately identifies SkinnyRx as one of several consumer-facing telehealth storefronts selling oral tirzepatide tablets, alleging (without SkinnyRx itself being a named defendant) that SkinnyRx's site "does not disclose any corporate leadership, ownership structure, clinical staff, prescribing entity, or pharmacy operations responsible for the issuance of prescriptions or fulfillment of medications sold through the platform." For branded medications (Wegovy, Zepbound, Mounjaro, and the investigational oral GLP-1 Foundayo), SkinnyRx's Terms state the medication purchase, dispensing, fulfillment, shipping, and billing are handled by a separate third-party pharmacy or manufacturer-affiliated program (its FAQ names NovoCare Pharmacy and LillyDirect as the manufacturer programs for this pathway), not by SkinnyRx.
Red flags on file33
Visit skinnyrx.com

Plain link, not sponsored — we take no payment for this.

Full profiles: Mochi Health · SkinnyRx
State-aware license reads: the tirzepatide price board →